Narinder P. Bhalla's most recent trade in Lexeo Therapeutics Inc. was a trade of 55,000 Common Stock done . Disclosure was reported to the exchange on June 29, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lexeo Therapeutics Inc | Narinder P. Bhalla | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2026 | 55,000 | 104,500 | - | 0 | Common Stock | |
| Lexeo Therapeutics Inc | Narinder P. Bhalla | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.42 per share. | 29 Jun 2026 | 22,306 | 82,194 | - | 4.4 | 98,593 | Common Stock |